Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Engert A

Collect these papers and discover other ones on Labmeeting. Learn more.

Activity of cetuximab as single agent in a patient with relapsed multiple myeloma.

+ cite this

Böll B, Eichenauer DA, Von Tresckow B, Peine D, Hallek M, Engert A, and Hübel K

Leukemia & lymphoma 51(3):562-4, 2010 Mar - Who cited this? | PubMed ID: 20095962 | Fulltext

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

+ cite this

+ View Abstract

Herbst C, Rehan FA, Brillant C, Bohlius J, Skoetz N, Schulz H, Monsef I, Specht L, and Engert A

Haematologica 95(3):494-500, 2010 Mar - Who cited this? | PubMed ID: 19951972 | Fulltext

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma.

+ cite this

Böll B, Borchmann P, Topp MS, Hänel M, Reiners KS, Engert A, and Naumann R

British journal of haematology 148(3):480-2, 2010 Feb - Who cited this? | PubMed ID: 19863533 | Fulltext

TNF-alpha-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species.

+ cite this

+ View Abstract

Vahdat AM, Reiners KS, Simhadri VL, Eichenauer DA, Böll B, Chalaris A, Simhadri VR, Wiegmann K, Krell HW, Rose-John S, Engert A, von Strandmann EP, and Hansen HP

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 24(1):51-7, 2010 Jan - Who cited this? | PubMed ID: 19890373 | Fulltext

Hodgkin's Lymphoma in Adolescents Treated With Adult Protocols: A Report From the German Hodgkin Study Group.

+ cite this

+ View Abstract

Eichenauer DA, Bredenfeld H, Haverkamp H, Müller H, Franklin J, Fuchs M, Borchmann P, Müller-Hermelink HK, Eich HT, Müller RP, Diehl V, and Engert A

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(36):6079-85, 2009 Dec 20 - Who cited this? | PubMed ID: 19901121 | Fulltext

Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?.

+ cite this

Eichenauer DA and Engert A

Leukemia & lymphoma 50(11):1733-4, 2009 Nov - Who cited this? | PubMed ID: 19883301 | Fulltext

Incidence of febrile neutropenia and myelotoxicity of chemotherapy: a meta-analysis of biosimilar G-CSF studies in breast cancer, lung cancer, and non-Hodgkin's lymphoma.

+ cite this

+ View Abstract

Engert A, del Giglio A, Bias P, Lubenau H, Gatzemeier U, and Heigener D

Onkologie 32(10):599-604, 2009 Oct - Who cited this? | PubMed ID: 19816079 | Fulltext

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

+ cite this

+ View Abstract

Engert A, Diehl V, Franklin J, Lohri A, Dörken B, Ludwig WD, Koch P, Hänel M, Pfreundschuh M, Wilhelm M, Trümper L, Aulitzky WE, Bentz M, Rummel M, Sezer O, Müller-Hermelink HK,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(27):4548-54, 2009 Sep 20 - Who cited this? | PubMed ID: 19704068 | Fulltext

Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.

+ cite this

+ View Abstract

Böll B, Eltaib F, Reiners KS, von Tresckow B, Tawadros S, Simhadri VR, Burrows FJ, Lundgren K, Hansen HP, Engert A, and von Strandmann EP

Clinical cancer research : an official journal of the American Association for Cancer Research 15(16):5108-16, 2009 Aug 15 - Who cited this? | PubMed ID: 19671844 | Fulltext

Epoetins and mortality in patients with cancer - Authors' reply.

+ cite this

Bohlius J, Trelle S, and Engert A

Lancet 374(9686):287-8, 2009 Jul 25 - Who cited this? | PubMed ID: 19632485 | Fulltext

FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.

+ cite this

+ View Abstract

Markova J, Kobe C, Skopalova M, Klaskova K, Dedeckova K, Plütschow A, Eich HT, Dietlein M, Engert A, and Kozak T

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 20(7):1270-4, 2009 Jul - Who cited this? | PubMed ID: 19228806 | Fulltext

Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.

+ cite this

+ View Abstract

Reiners KS, Gossmann A, von Strandmann EP, Böll B, Engert A, and Borchmann P

Journal of immunotherapy (Hagerstown, Md. : 1997) 32(5):508-12, 2009 Jun - Who cited this? | PubMed ID: 19609243 | Fulltext

Ninth biannual report of the cochrane haematological malignancies group--focus on hematopoietic growth factors.

+ cite this

Skoetz N, Weingart O, Monsef I, Bauer K, Brillant C, Herbst C, Kluge S, and Engert A

Journal of the National Cancer Institute 101(9):E1, 2009 May 6 - Who cited this? | PubMed ID: 19401542 | Fulltext

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

+ cite this

+ View Abstract

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I,

(show remaining authors)

Lancet 373(9674):1532-42, 2009 May 2 - Who cited this? | PubMed ID: 19410717 | Fulltext

Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

+ cite this

Engert A, Eichenauer DA, Dreyling M, and ESMO Guidelines Working Group

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 20 Suppl 4:108-9, 2009 May - Who cited this? | PubMed ID: 19454425 | Fulltext

Biomarkers and prognosis in malignant lymphomas.

+ cite this

+ View Abstract

Hagenbeek A, Gascoyne RD, Dreyling M, Kluin P, Engert A, and Salles G

Clinical lymphoma & myeloma 9(2):160-6, 2009 Apr - Who cited this? | PubMed ID: 19406728 | Fulltext

XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy.

+ cite this

+ View Abstract

Engert A, Griskevicius L, Zyuzgin Y, Lubenau H, and Del Giglio A

Leukemia & lymphoma 50(3):374-9, 2009 Mar - Who cited this? | PubMed ID: 19347726 | Fulltext

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.

+ cite this

+ View Abstract

Pels H, Juergens A, Glasmacher A, Schulz H, Engert A, Linnebank M, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Lamprecht M, Hau P, Deckert M,

(show remaining authors)

Journal of neuro-oncology 91(3):299-305, 2009 Feb - Who cited this? | PubMed ID: 18931887 | Fulltext

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.

+ cite this

+ View Abstract

Reimer P, Rüdiger T, Geissinger E, Weissinger F, Nerl C, Schmitz N, Engert A, Einsele H, Müller-Hermelink HK, and Wilhelm M

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(1):106-13, 2009 Jan 1 - Who cited this? | PubMed ID: 19029417 | Fulltext

Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia.

+ cite this

Elter T, Kilp J, Borchmann P, Schulz H, Hallek M, and Engert A

Haematologica 94(1):150-2, 2009 Jan - Who cited this? | PubMed ID: 19001286 | Fulltext

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy.

+ cite this

+ View Abstract

Herbst C, Naumann F, Kruse EB, Monsef I, Bohlius J, Schulz H, and Engert A

Cochrane database of systematic reviews (Online)(1):CD007107, 2009 - Who cited this? | PubMed ID: 19160320 | Fulltext

Combined Modality Treatment of Hodgkin's Lymphoma.

+ cite this

+ View Abstract

Klimm B and Engert A

Cancer journal (Sudbury, Mass.) 15(2):143-9, 2009 - Who cited this? | PubMed ID: 19390310 | Fulltext

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data.

+ cite this

+ View Abstract

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF,

(show remaining authors)

Cochrane database of systematic reviews (Online)(3):CD007303, 2009 - Who cited this? | PubMed ID: 19588423 | Fulltext

Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.

+ cite this

Bohlius J, Engert A, and Schwarzer G

JAMA : the journal of the American Medical Association 300(24):2854-5; author reply 2855-7, 2008 Dec 24 - Who cited this? | PubMed ID: 19109112 | Fulltext

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.

+ cite this

+ View Abstract

Kobe C, Dietlein M, Franklin J, Markova J, Lohri A, Amthauer H, Klutmann S, Knapp WH, Zijlstra JM, Bockisch A, Weckesser M, Lorenz R, Schreckenberger M, Bares R, Eich HT, Mueller RP,

(show remaining authors)

Blood 112(10):3989-94, 2008 Nov 15 - Who cited this? | PubMed ID: 18757777 | Fulltext

Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma.

+ cite this

+ View Abstract

Rautert R, Schinkothe T, Franklin J, Weihrauch M, Boll B, Pogge E, Bredenfeld H, Engert A, Diehl V, and Re D

Leukemia & lymphoma 49(11):2091-8, 2008 Nov - Who cited this? | PubMed ID: 19021051 | Fulltext

Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.

+ cite this

+ View Abstract

Sieniawski M, Reineke T, Josting A, Nogova L, Behringer K, Halbsguth T, Fuchs M, Diehl V, and Engert A

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 19(10):1795-801, 2008 Oct - Who cited this? | PubMed ID: 18544558 | Fulltext

Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis.

+ cite this

Quellmann S, Schwarzer G, Hübel K, Engert A, and Bohlius J

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 22(9):1801-3, 2008 Sep - Who cited this? | PubMed ID: 18449206 | Fulltext

Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab.

+ cite this

+ View Abstract

Elter T, Vehreschild JJ, Gribben J, Cornely OA, Engert A, and Hallek M

Annals of hematology, 2008 Aug 6 - Who cited this? | PubMed ID: 18682948 | Fulltext

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia.

+ cite this

Herbst C, Monsef I, Skötz N, and Engert A

Journal of the National Cancer Institute 100(15):E1, 2008 Aug 6 - Who cited this? | PubMed ID: 18664654 | Fulltext

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.

+ cite this

+ View Abstract

Hagenbeek A, Gadeberg O, Johnson P, Pedersen LM, Walewski J, Hellmann A, Link BK, Robak T, Wojtukiewicz M, Pfreundschuh M, Kneba M, Engert A, Sonneveld P, Flensburg M, Petersen J, Losic N,

(show remaining authors)

Blood 111(12):5486-95, 2008 Jun 15 - Who cited this? | PubMed ID: 18390837 | Fulltext

Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies.

+ cite this

+ View Abstract

Klimm B and Engert A

Nature clinical practice. Oncology 5(6):316-23, 2008 Jun - Who cited this? | PubMed ID: 18461068 | Fulltext

Treatment of lymphocyte-predominant Hodgkin lymphoma.

+ cite this

Engert A

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 19 Suppl 4:iv45-6, 2008 Jun - Who cited this? | PubMed ID: 18519402 | Fulltext

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.

+ cite this

+ View Abstract

Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M,

(show remaining authors)

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 6(5):366-73, 2008 May - Who cited this? | PubMed ID: 18201220 | Fulltext

Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

+ cite this

Engert A, Dreyling M, and ESMO Guidelines Working Group

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 19 Suppl 2:ii65-6, 2008 May - Who cited this? | PubMed ID: 18456773 | Fulltext

Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Jensen M, Engert A, Weissinger F, Knauf W, Kimby E, Poynton C, Oliff IA, Rummel MJ, and Osterborg A

Investigational new drugs 26(2):139-49, 2008 Apr - Who cited this? | PubMed ID: 18094935 | Fulltext

Ribosome display and selection of human anti-cD22 scFvs derived from an acute lymphocytic leukemia patient.

+ cite this

+ View Abstract

Rothe A, Nathanielsz A, Oberhäuser F, von Pogge SE, Engert A, Hudson PJ, and Power BE

Biological chemistry 389(4):433-9, 2008 Apr - Who cited this? | PubMed ID: 18225987 | Fulltext

Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.

+ cite this

+ View Abstract

Schnell R, Dietlein M, Schomäcker K, Kobe C, Borchmann P, Schicha H, Hallek M, and Engert A

Onkologie 31(1-2):49, 2008 Feb - Who cited this? | PubMed ID: 18268399 | Fulltext

Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.

+ cite this

+ View Abstract

Nogová L, Reineke T, Brillant C, Sieniawski M, Rüdiger T, Josting A, Bredenfeld H, Skripnitchenko R, Müller RP, Müller-Hermelink HK, Diehl V, Engert A, and German Hodgkin Study Group

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(3):434-9, 2008 Jan 20 - Who cited this? | PubMed ID: 18086799 | Fulltext

Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation.

+ cite this

+ View Abstract

Quellmann S, Schwarzer G, Hübel K, Greb A, Engert A, and Bohlius J

Cochrane database of systematic reviews (Online)(3), 2008 - Who cited this? | PubMed ID: 18646116 | Fulltext

Radiotherapy Does Not Influence the Severe Pulmonary Toxicity Observed With the Administration of Gemcitabine and Bleomycin in Patients With Advanced-Stage Hodgkin's Lymphoma Treated With the BAGCOPP Regimen: A Report by the German Hodgkin's Lymphoma Study Group.

+ cite this

+ View Abstract

Macann A, Bredenfeld H, Müller RP, Diehl V, Engert A, and Eich HT

International journal of radiation oncology, biology, physics 70(1):161-5, 2008 Jan 1 - Who cited this? | PubMed ID: 17855012 | Fulltext

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).

+ cite this

+ View Abstract

Sieniawski M, Reineke T, Nogova L, Josting A, Pfistner B, Diehl V, and Engert A

Blood 111(1):71-6, 2008 Jan 1 - Who cited this? | PubMed ID: 17890456 | Fulltext

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

+ cite this

+ View Abstract

Schulz H, Rehwald U, Morschhauser F, Elter T, Driessen C, Rüdiger T, Borchmann P, Schnell R, Diehl V, Engert A, and Reiser M

Blood 111(1):109-11, 2008 Jan 1 - Who cited this? | PubMed ID: 17938252 | Fulltext

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults.

+ cite this

+ View Abstract

Greb A, Bohlius J, Schiefer D, Schwarzer G, Schulz H, and Engert A

Cochrane database of systematic reviews (Online)(1):CD004024, 2008 - Who cited this? | PubMed ID: 18254036 | Fulltext

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.

+ cite this

+ View Abstract

Bohlius J, Herbst C, Reiser M, Schwarzer G, and Engert A

Cochrane database of systematic reviews (Online)(4):CD003189, 2008 - Who cited this? | PubMed ID: 18843642 | Fulltext

Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function.

+ cite this

+ View Abstract

Simhadri VR, Reiners KS, Hansen HP, Topolar D, Simhadri VL, Nohroudi K, Kufer TA, Engert A, and Pogge von Strandmann E

PLoS ONE 3(10):e3377, 2008 - Who cited this? | PubMed ID: 18852879 | Fulltext

[FDG-PET in Hodgkin lymphoma].

+ cite this

+ View Abstract

Kobe C, Dietlein M, Mauz-Körholz C, Engert A, Borchmann P, Sabri O, Schober O, Schicha H, and Kluge R

Nuklearmedizin. Nuclear medicine 47(6):235-8; quiz N75-6, 2008 - Who cited this? | PubMed ID: 19057796 | Fulltext

Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells.

+ cite this

+ View Abstract

Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, Rothe A, Böll B, Simhadri VL, Borchmann P, McKinnon PJ, Hallek M, and Engert A

Immunity 27(6):965-74, 2007 Dec - Who cited this? | PubMed ID: 18055229 | Fulltext

A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).

+ cite this

+ View Abstract

Eich HT, Gossmann A, Engert A, Kriz J, Bredenfeld H, Hansemann K, Skripnitchenko R, Brillant C, Pfistner B, Staar S, Diehl V, Müller RP, and German Hodgkin Study Group

International journal of radiation oncology, biology, physics 69(4):1187-92, 2007 Nov 15 - Who cited this? | PubMed ID: 17703895 | Fulltext

Hodgkin's lymphoma: new insights in an old disease. Preface.

+ cite this

Diehl V, Engert A, and Re D

Hematology/oncology clinics of North America 21(5):xiii-xiv, 2007 Oct - Who cited this? | PubMed ID: 17908618 | Fulltext

Search Google Scholar for Engert A

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.